Back to Journals » Drug Design, Development and Therapy » Volume 15

Consolidation Treatment and Long-Term Prognosis of Rituximab in Minimal Change Disease and Focal Segmental Glomerular Sclerosis

Total article views   HTML views PDF downloads Totals
6,122 Dovepress* 5,396+ 533 5,929
PubMed Central* 726 351 1,077
Totals 6,122 884 7,006
*Since 10 May 2021

View citations on PubMed Central and Google Scholar